Eslicarbazepine Acetate
CAS No. 236395-14-5
Eslicarbazepine Acetate( BIA 2-093 )
Catalog No. M13678 CAS No. 236395-14-5
Eslicarbazepine acetate is an antiepileptic drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 41 | In Stock |
|
| 25MG | 76 | In Stock |
|
| 50MG | 113 | In Stock |
|
| 100MG | 156 | In Stock |
|
| 200MG | 254 | In Stock |
|
| 500MG | 372 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEslicarbazepine Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEslicarbazepine acetate is an antiepileptic drug.
-
DescriptionEslicarbazepine acetate is an antiepileptic drug. (In Vivo):Eslicarbazepine acetate is an antiepileptic drug. It is a prodrug which is activated to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine. Eslicarbazepine acetate is a prodrug for (S)-(+)-licarbazepine, the major active metabolite of oxcarbazepine. Its mechanism of action is therefore identical to that of oxcarbazepine. Eslicarbazepine acetate may not produce as high peak levels of (S)-(+)-licarbazepine immediately after dosing as does oxcarbazepine which could theoretically improve tolerability.
-
In Vitro——
-
In VivoEslicarbazepine acetate is an antiepileptic drug. It is a prodrug which is activated to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine. Eslicarbazepine acetate is a prodrug for (S)-(+)-licarbazepine, the major active metabolite of oxcarbazepine. Its mechanism of action is therefore identical to that of oxcarbazepine. Eslicarbazepine acetate may not produce as high peak levels of (S)-(+)-licarbazepine immediately after dosing as does oxcarbazepine which could theoretically improve tolerability.
-
SynonymsBIA 2-093
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number236395-14-5
-
Formula Weight296.324
-
Molecular FormulaC17H16N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 59 mg/mL (199.1 mM)/Ethanol: 11 mg/mL (37.12 mM)
-
SMILESO=C(N1C2=CC=CC=C2C[C@H](OC(C)=O)C3=CC=CC=C31)N
-
Chemical Name(S)-10-Acetoxy- 10,11-dihydro- 5H-dibenz[b,f]azepine- 5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sierra-Paredes G, et al. BMC Neurosci. 2014, 15:134.
molnova catalog
related products
-
Gp100 619-627
This is a HLA-A*0201 restricted epitope used in melanoma studies.
-
α-Factor Mating Pher...
The alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. Alpha Factor Mating Pheromone induces the expression of mating genes, changes in nuclear architecture, and polarzes growth toward the mating partner.
-
JR14a
JR14a is a potent antagonist of human complement C3a receptor.
Cart
sales@molnova.com